Why is "Antimalarial" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-04 06:13:08
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Antimalarial entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-04 and was most recently seen on 2026-05-04.
Wikipedia Overview
Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women. While many treatments, including for severe malaria, continue to depend on therapies deriving historically from the injectable drugs quinine and artesunate, the development of drug resistance in the parasite has necessitated the development new antimalarial therapies. Though antimalarial drugs have repeatedly been observed to elicit resistance in the malaria parasite—including for combination therapies featuring artemisinin, where resistance has previously been observed in Southeast Asia, Artemisinin-based combination therapies (ACTs) have remained the foundational treatment for falciparum malaria globally as of 2024. Incidence and distribution of the disease is expected to remain high, globally, for many years to come. Despite positive outcomes from various modern treatments, serious side effects have been seen to affect some individuals taking standard doses.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
APMEN TechTalks Webinar: Expanding Pediatric Antimalarial Treatment - Medicines for Malaria Venture
-
Potent acridone antimalarial against all three life stages of Plasmodium - Nature
-
Compendium of molecular markers for antimalarial drug resistance - World Health Organization (WHO)
-
Innovative approach in malaria research: Harnessing CRISPR-Cas9 for antimalarial drug-resistance studies in Africa - ScienceDirect.com
-
Genome-Guided Discovery of Antimalarial 4-Amino-2,4-Pentadienoate-Containing Cyclolipodepsipeptides - Wiley Online Library
-
Staying ahead of antimalarial drug resistance - PATH
-
U.S. researchers report new antimalarial compounds - BioWorld News
-
Battling antimalarial drug resistance - Harvard T.H. Chan School of Public Health
-
Validated antimalarial drug target discovery using genome-scale metabolic modeling - ASM Journals
-
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum - Nature
-
A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum - Wiley Online Library
-
Spatial and temporal description of antimalarial drug resistance markers in Ghana using targeted amplicon deep sequencing - ASM Journals
-
WHO prequalifies first-ever malaria treatment for newborns and infants, adds new diagnostic tests - World Health Organization (WHO)
-
Endogenous structure of antimalarial target PfATP4 reveals an apicomplexan-specific P-type ATPase modulator - Nature
-
Antimalarial potential of curcumin derivatives evaluated through experimental and computational approaches - Nature
-
Novel antimalarial passes key phase III test - Nature
-
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019–2024 - Nature
-
Scalable and cost-effective methods for xenomonitoring of P. falciparum and antimalarial drug resistance validated with laboratory and wild-caught mosquitoes - Nature
-
Unlocking the antimalarial potential of novel steroid-tetraoxane hybrids through consensus molecular docking and molecular dynamics investigation - Nature
-
Computational insights into harmala alkaloids as novel antimalarial candidates against Plasmodium falciparum - Nature
-
Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance - Science | AAAS
-
Next-Generation Antimalarial Chemotypes: Innovative Inhibitors Addressing Transmissible Stages and Disease Symptoms with Novel Mechanisms of Action - Frontiers
-
Integrated structural biology of the native malarial translation machinery and its inhibition by an antimalarial drug - Nature
-
Methods and thresholds used in the compendium of molecular markers for antimalarial drug resistance - World Health Organization (WHO)
-
Updated guidelines for malaria prevention in travellers from the UK - NaTHNaC
-
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies - ASM Journals
-
New antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission - Walter and Eliza Hall Institute of Medical Research
-
Antimalarial activity of root extract of Tephrosia villosa L. Pers. (Fabaceae) on Plasmodium berghei- infected mice - Nature
-
Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments - Scripps Research
-
Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs - News-Medical
-
Africa Needs To Take Urgent Action To Protect ‘Miracle’ Malaria Drugs - Health Policy Watch
-
Unitaid and Jhpiego launch US$26.5 million initiative to curb rising antimalarial drug resistance in Africa - Unitaid
-
Malaria drug may help treat eye inflammation in ocular sarcoidosis - Sarcoidosis News
-
Liquid-Phase Peptide Synthesis of Tropolone–Peptide Hybrid Antimalarials - ACS Publications
-
Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies - MedCity News
-
The efficacy of selected Ghanaian herbal antimalarials against laboratory strains and clinical isolates of Plasmodium falciparum - Nature
-
Antimalarial drug hunt uncovers enzyme target with potent new inhibitors - Phys.org
-
Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study - BMJ Global Health
-
Tracking Plasmodium falciparum antimalarial resistance markers during a malaria pre-elimination period in the Pacific coast of South America - Nature
-
MMV and Noguchi Memorial Institute partner to accelerate antimalarial drug discovery - Medicines for Malaria Venture
-
WHO Certifies Countries as Malaria Free in Face of Persistent Antimalarial Drug Resistance - Contagion Live
-
Malaria: Drug resistance and underfunding threaten progress towards eliminating killer disease - UN News
-
Diversifying antimalarial treatment for uncomplicated Plasmodium falciparum malaria in Uganda - The Lancet
-
Drug-resistant malaria poses growing challenge to treatment and elimination efforts - The Hindu
-
‘A sigh of relief’: New malaria drug succeeds in large clinical trial - Science | AAAS
-
Drexel Researchers Gain New Insights from Malaria-Causing Parasite That May Support Development of Future Antimalarial Drugs - Drexel
-
Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax - Nature
-
Knowledge, beliefs and adherence to antimalarial medications among patients in the Ga East Municipality of Ghana - Frontiers
-
Novartis, MMV & WHO: Securing a Newborn Antimalarial Drug - Healthcare Digital
-
Veterans lawsuit against makers of antimalarial drug gets new life on appeal - Stars and Stripes
-
Health: How Benin is tackling resistance to antimalarial drugs - Table.Briefings
-
RGCB scientists uncover new mechanism behind malaria parasite’s drug resistance - ThePrint
-
Looming Malaria Drug Resistance Spurs Global Search For New Treatments - Health Policy Watch
-
Novartis says Phase 3 data prove new antimalarial could address resistance - Endpoints News
-
‘Music To Our Ears’: A New Malaria Treatment May Offer Long-Awaited Alternative to Artemisinin - Global Health NOW
-
WHO approves first child-friendly primaquine formulations for malaria treatment - Unitaid
-
Multiple first-line therapies as part of the response to antimalarial drug resistance - World Health Organization (WHO)
-
Australia develops new antimalarial drug candidate to address growing challenge of drug resistance - BioSpectrum Asia
-
Plasmodium telomere maintenance: uncovering the Achilles’ heel for novel antimalarials - Frontiers
-
Drug Resistance in the Malaria-Endemic World - Centers for Disease Control and Prevention | CDC (.gov)
-
In Vivo Antimalarial Activity and Toxicological Profile of LAFIS10, a Piperazine Derivative From Ursolic Acid - Wiley Online Library
-
Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial - News-Medical
-
Antimalarial drug is effective against tick-borne infection babesiosis - Yale School of Public Health
-
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies - Nature
-
The first drug to treat infants sick with malaria is approved by Swiss authority - AP News
-
WHO prequalifies Novartis' antimalarial Coartem Baby for treatment of newborns and young infants - Manufacturing Chemist
-
Antimalarial drug discovery: progress and approaches - Nature
-
Isolation and validation of antimalarial compounds from Phyllanthus emblica leaves for new antimalarial drug development - Nature
-
Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy - World Health Organization (WHO)
-
Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design - Nature
-
Antimalarial-Mediated Cardiotoxicity: Evaluation and Preliminary Screening Recommendations For Patients on Chronic Therapy for Autoimmune Rheumatic Diseases - American College of Cardiology
-
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target - Science | AAAS
-
Antimalarial-treated bed nets could stop parasites developing in mosquitoes - Nature
-
First malaria treatment for babies approved for use - BBC
-
Propensity of selecting mutant parasites for the antimalarial drug cabamiquine - Nature
-
CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial - Nature
-
The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC - Nature
-
New Malaria Drug Candidate Exceeds Cure Rate For Standard ACTs In Phase 3 Trial - Health Policy Watch
-
Tackling emerging antimalarial drug resistance in Africa - World Health Organization (WHO)
-
Medication and Vaccine Interactions in Travel Medicine | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)
-
In vitro and in vivo antimalarial activity and chemical profiling of sugarcane leaves - Nature
-
Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax - Nature
-
The Origins of Antimalarial-Drug Resistance - The New England Journal of Medicine
-
Oral Administration of Clinically Relevant Antimalarial Drugs Does Not Modify the Murine Gut Microbiota - Nature
-
New genetic markers could help track emerging malaria drug resistance - The London School of Hygiene & Tropical Medicine
-
Malaria Medications: The Link to Veteran Health Woes - DAV : Disabled American Veterans
-
Alternative and Novel Drug Based Prevention Approaches | Malaria - Centers for Disease Control and Prevention | CDC (.gov)
-
Clinically applicable parasite viability assay for rapid assessment of antimalarial pharmacodynamic endpoints - ASM Journals
-
A machine learning approach to define antimalarial drug action from heterogeneous cell-based screens - Science | AAAS
-
Antimalarial activity of primaquine operates via a two-step biochemical relay - Nature
-
Professor Sir Nicholas J White (1951 – 2026): a visionary infectious diseases clinician scientist and mentor par excellence - University of Cape Town
-
Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases - Nature
-
The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility - Science | AAAS
-
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial - Nature
-
Team Science Leads to Antimalarial Drug Discovery - Yale School of Medicine
-
The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957 - Nature
-
Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine - PNAS
-
Anti-Malarial Drugs Market Size, Share, Growth, Analysis, 2034 - Straits Research
-
From Black to Grey: Improving Access to Antimalarial Drugs in the Presence of Deceptive Counterfeits - Nanyang Technological University - NTU Singapore
-
Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.